Earlier studies have indicated a higher prevalence of GS in females compared to males (22, 23), which may be because of estrogen-induced increase in the synthesis and secretion of hepatic cholesterol by increasing the expression of estrogen receptor 1 and G protein-coupled receptor 30 as well as decreased bile salt synthesis, and ultimately promoting GS development (24). Here, ESR1 is linked to Gerstmann syndrome.